Skip to content
Nonprofiteer
← CLAYTON FOUNDATION FOR RESEARCH

Form 990 for tax year 2024

Filed by CLAYTON FOUNDATION FOR RESEARCH.

Totals

Total revenue
$14,857,333
Total expenses
$10,938,202
Contributions and grants received
$2,025,000
Grants paid
$51,500
Program service revenue
$0
Investment income
$12,739,333
Other revenue
$93,000
Total assets, end of year
$144,353,789
Total liabilities, end of year
$6,584,095
Net assets or fund balances, end of year
$137,769,694
Program services expenses (Part IX)
$9,071,928
Management and general expenses
$1,866,274
Fundraising expenses
$0
Program service expenses (Part III)
$9,071,928

Program services were 82.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1d · Related organizations

    $2,025,000

  • 3 · Investment income

    total $2,405,499 · excluded $2,405,499

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $93,000 · excluded $93,000

  • 6d · Net rental income or loss

    total $0

  • 7a · Gross sales of assets other than inventory

    securities $11,372,119

  • 7b · Less cost or other basis and sales expenses

    securities $1,038,285

  • 7c · Gain or loss

    securities $10,333,834

  • 7d · Net gain or loss

    total $10,333,834 · excluded $10,333,834

  • 8c · Net income from fundraising events

    total $0

  • 9c · Net income from gaming

    total $0

  • 10c · Net income from sales of inventory

    total $0

  • 11e · Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $51,500 · program services $51,500

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $1,666,825 · program services $930,273 · management and general $736,552

  • 6 · Compensation of disqualified persons

    total $589,844 · program services $412,891 · management and general $176,953

  • 7 · Other salaries and wages

    total $2,825,950 · program services $2,669,369 · management and general $156,581

  • 8 · Pension plan contributions

    total $334,099 · program services $309,157 · management and general $24,942

  • 9 · Other employee benefits

    total $1,121,848 · program services $1,031,710 · management and general $90,138

  • 10 · Payroll taxes

    total $206,033 · program services $166,775 · management and general $39,258

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $22,306 · program services $16,730 · management and general $5,576

  • 11c · Fees: accounting

    total $53,757 · program services $43,006 · management and general $10,751

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $341,081 · management and general $341,081

  • 11g · Fees: other

    total $58,742 · program services $46,390 · management and general $12,352

  • 12 · Advertising and promotion

    total $0

  • 13 · Office expenses

    total $94,463 · program services $67,069 · management and general $27,394

  • 14 · Information technology

    total $0

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $0

  • 17 · Travel

    total $39,534 · program services $39,534

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $0

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $398,768 · program services $283,125 · management and general $115,643

  • 23 · Insurance

    total $239,083 · program services $207,997 · management and general $31,086

  • 24a · Other expenses: Medical research supplies

    total $1,545,511 · program services $1,545,511

  • 24b · Other expenses: Charge for research lab use

    total $803,705 · program services $803,705

  • 24c · Other expenses: Research equipment

    total $237,107 · program services $237,107

  • 24d · Other expenses: Tuition for researchers

    total $94,959 · program services $94,959

  • 24e · All other expenses

    total $213,087 · program services $115,120 · management and general $97,967

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,750,906 · end of year $634,743

  • 2 · Savings and temporary cash investments

    end of year $0

  • 3 · Pledges and grants receivable

    end of year $0

  • 4 · Accounts receivable

    beginning of year $245,846 · end of year $373,726

  • 5 · Loans and receivables from officers and key people

    end of year $0

  • 6 · Loans and receivables from disqualified persons

    end of year $0

  • 7 · Other notes and loans receivable

    end of year $0

  • 8 · Inventories for sale or use

    end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $200,426 · end of year $179,407

  • 10a · Land, buildings and equipment: cost or other basis

    $4,434,562

  • 10b · Land, buildings and equipment: accumulated depreciation

    $2,289,075

  • 10c · Land, buildings and equipment, net

    beginning of year $2,544,256 · end of year $2,145,487

  • 11 · Investments: publicly traded securities

    beginning of year $101,051,932 · end of year $102,655,928

  • 12 · Investments: other securities

    end of year $0

  • 13 · Investments: program-related

    end of year $0

  • 14 · Intangible assets

    end of year $0

  • 15 · Other assets

    beginning of year $24,779,102 · end of year $38,364,498

  • 17 · Accounts payable and accrued expenses

    beginning of year $7,121,038 · end of year $6,584,095

  • 27 · Net assets without donor restrictions

    beginning of year $82,886,840 · end of year $97,145,314

  • 28 · Net assets with donor restrictions

    beginning of year $40,564,590 · end of year $40,624,380

Mission and programs · 2024

Mission

The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through the Foundation's supporting entities.

Activities or mission (Part I)

The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind.

  • Withheld by Nonprofiteer: this text may name a private individual.

    Expenses $1,030,206

  • A research project at Baylor College of Medicine in gene and protein therapy focuses on inappropriate cell division and cell death within the human body. Much of the work is devoted to intraocular angiogenesis, with particular attention to: (1) the signals that control this process, (2) the development of animal models of human ocular disease, and (3) development of potential therapies. New targets have been identified and potential therapeutic agents are being developed and tested for the treatment of wet AMD, Diabetic Retinopathy, and Retinopathy of Prematurity.

    Expenses $964,510

  • The conduct of a longstanding research program at the University of Texas M. D. Anderson Cancer Center(which program moved to Texas A&M Institute of Biosciences and and Technology during the year) , the purpose of which is to design and develop novel targeted therapeutic agents that target a powerful human toxin to specifically destroy cancer cells for the treatment of numerous cancer targets and other disease indications. A number of collaborations have been undertaken with researchers at various institutions (e.g., University of California San Diego). Patent applications have been filed by Research Development Foundation (RDF), a tax exempt supporting organization of the Foundation (see schedule R, Part III), on more than twenty discoveries, and a number of patents have been issued. Licensing efforts have been ongoing and have resulted in several licenses.

    Expenses $910,134

  • Vaccines, Diagnostics and Therapeutics for the Ehrlichioses at The Univerity of Texas Medical Branch at Galveston

    Expenses $825,546

  • Development of Biorepository and Novel Therapeutic Strategies for Hepatocellular Carcinoma at the University of Texas Health Science Center at San Antonio

    Expenses $807,116

  • Early Detection and Treatment of Glaucoma Baylor College of Medicine Houston

    Expenses $674,935

  • Identification of Host-based Antiviral Targets at the University of Texas Southwestern Medical Center Dallas

    Expenses $637,144

  • The Use of Light for Cardiological, Surgical, and Related Purposes at the University of Texas Health Science Center at San Antonio

    Expenses $622,259

  • Antibody Discovery and Optimization Using the Eclonal Technology at The University of Texas at Austin

    Expenses $589,586

  • Electroceutical Sciences and Medicine at Dell Medical School at the University of Texas

    Expenses $495,150

  • Developing Drug Delivery Systems for Testing Solid Tumors at Dell Medical School at the University of Texas

    Expenses $491,527

  • Discovering New Mechanisms and Therapeutics for Brain Injury at the University of Texas Southwestern Medical Center Dallas

    Expenses $425,701

  • Development of Artificial Neurotransmitter Systems at the University of Texas at Austin

    Expenses $361,410

  • Optimization and Charactorization of AAV for Gene Therapy at Dell Medical School at The University of Texas

    Expenses $236,704

  • Grants

    Grants $51,500

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.

Listed in Part VII

  • Jarred W Sloan

    Trustee, President, Treasurer

    Total calculated
    $785,428
    From this org
    $283,402
    From related orgs
    $402,613
    Other
    $99,413
    Hours/week
    20 + 20 related

    Schedule J breakdown matched by us

    Base
    $283,402 + $402,613 related
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $77,484 + $21,929 related
    Filer's total
    $360,886 + $424,542 related

  • Robert M Wallace

    Trustee, Vice President

    Total calculated
    $785,428
    From this org
    $210,286
    From related orgs
    $475,729
    Other
    $99,413
    Hours/week
    20 + 20 related

    Schedule J breakdown matched by us

    Base
    $210,286 + $475,729 related
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $77,484 + $21,929 related
    Filer's total
    $287,770 + $497,658 related

  • Lynn P Carter

    Trustee

    Total calculated
    $785,428
    From this org
    $100,624
    From related orgs
    $585,391
    Other
    $99,413
    Hours/week
    8 + 32 related

    Schedule J breakdown matched by us

    Base
    $100,624 + $585,391 related
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    not reported + $99,413 related
    Filer's total
    $100,624 + $684,804 related

  • Joan S Dunlap

    Trustee VP, Secretary

    Total calculated
    $707,039
    From this org
    $159,140
    From related orgs
    $458,605
    Other
    $89,294
    Hours/week
    4 + 36 related

    Schedule J breakdown matched by us

    Base
    $159,140 + $458,605 related
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $58,967 + $30,327 related
    Filer's total
    $218,107 + $488,932 related

  • Brian W Crozier

    Trustee, Chairman

    Total calculated
    $406,898
    From this org
    $100,624
    From related orgs
    $256,424
    Other
    $49,850
    Hours/week
    5 + 10 related

    Schedule J breakdown matched by us

    Base
    $100,624 + $256,424 related
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $49,850
    Filer's total
    $150,474 + $256,424 related

  • Robert L Evans

    VP, Assistant Treasurer

    Total calculated
    $305,150
    From this org
    $222,000
    From related orgs
    $0
    Other
    $83,150
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $222,000
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $83,150
    Filer's total
    $305,150

  • Kimberly A Shipley

    Assistant Secretary

    Total calculated
    $254,780
    From this org
    $178,200
    From related orgs
    $0
    Other
    $76,580
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $178,200
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $76,580
    Filer's total
    $254,780

  • Lawrence H Cheung

    Project Researcher

    Total calculated
    $154,436
    From this org
    $114,406
    From related orgs
    $0
    Other
    $40,030
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $114,406
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $40,030
    Filer's total
    $154,436

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · First-class or charter travel
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Part I, Line 1a: Relevant information in regards to selections on 1a.
Part II, Compensation from Unrelated Organizations
Part I Line 1a: Foundation representatives on Foundation business may travel first class under the travel policy approved by the Board, but such persons sometimes fly economy, depending upon routes and convenience of flight schedules. The travel policy does not permit charter travel, and no charter travel was provided to any of such persons.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • Foundation Services Inc

    C · Holding Company · NV

    Directly controlled by NA

  • Clayton Biotechnologies Inc

    C · Technology Transfer · NV · controlled entity

    Directly controlled by Found Services Inc

  • Julie Davis Clayton Trust

    T · Charitable Remainder Trust · TX

    Directly controlled by Clayton Foundation

Provenance

Return type
form_990
Tax year
2024
Filed
17 November 2025
IRS schema version
2024v5.2
Source object
202523219349307322

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.